NASDAQ:EKSO
Ekso Bionics Holdings Stock News
$1.28
-0.0400 (-3.03%)
At Close: Apr 22, 2024
General Automation Lab Technologies and CosmosID Launch Second Microbiome Challenge
12:00am, Tuesday, 11'th Aug 2020
Winner will receive complimentary sample processing and analysis for high-throughput characterization of microbial communities.
This week in Washington IP, both houses of Congress are quiet during August recess but patent and IP policy issues are front and center at the Hudson Institute, which is hosting events to explore how
CENIC Extends 400G Capabilities to Coastal Path Between Los Angeles and Sunnyvale
12:00am, Friday, 07'th Aug 2020
CENIC is now able to provide high-capacity services, from 100G to 400G and beyond, on its coastal path between Los Angeles and Sunnyvale. The research
White House unveils partnership to boost quantum science education
12:00am, Wednesday, 05'th Aug 2020
White House unveils partnership to boost quantum science education
Ekso Bionics (NASDAQ:EKSO) Receives “Buy” Rating from HC Wainwright
06:18am, Tuesday, 04'th Aug 2020
HC Wainwright restated their buy rating on shares of Ekso Bionics (NASDAQ:EKSO) in a research report released on Friday, AnalystRatings.com reports. HC Wainwright currently has a $12.00 price target o
IgGenix Completes $10 Million Series A Financing
12:00am, Tuesday, 04'th Aug 2020
IgGenix, Inc, today announced it completed a $10 million Series A financing. The financing was led by Khosla Ventures with participation from Parker V
Fluidigm COVID-19 Funding, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:FLDM)
12:03pm, Monday, 03'rd Aug 2020
Fluidigm receives NIH funding for COVID-19 testing technology. Stereotaxis receives positive fillip from first integrated cardiac ablation procedure.
AbCellera today announced that LY-CoV555, a potential treatment and prophylaxis for COVID-19, has progressed to Phase 3 clinical trials.
US Covid testing has been a historic catastrophe. Is Trump’s testing tsar Brett Giroir to blame?
07:00am, Friday, 31'st Jul 2020
Giroir’s qualifications have come under increasing scrutiny as the US death toll tops 150,000, and testing continues to lag
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates
11:10pm, Thursday, 30'th Jul 2020
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics Reports Second Quarter 2020 Results
08:05pm, Thursday, 30'th Jul 2020
RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today r
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2020 Results - Earnings Call Transcript
08:01pm, Thursday, 30'th Jul 2020
Start Time: 16:30 End Time: 17:00 Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2020 Earnings Conference Call July 30, 2020, 16:30 PM ET Company Participants Jack Peurach - President and CEO Jack Glenn
Will Delayed Orders Hurt Ekso Bionics (EKSO) Q2 Earnings?
03:22pm, Monday, 27'th Jul 2020
Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.
Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long
12:07am, Saturday, 25'th Jul 2020
In 2021 university teams will compete in an autonomous-car race at Indianapolis Motor Speedway. It’s a reminder how difficult the technology behind autonomous driving is.
Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
12:00pm, Thursday, 23'rd Jul 2020
RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it wil